Big Players' Recent Trades in JNJ Options

Whales with a lot of money to spend have taken a noticeably bullish stance on Johnson & Johnson.

Looking at options history for Johnson & Johnson JNJ we detected 10 trades.

If we consider the specifics of each trade, it is accurate to state that 70% of the investors opened trades with bullish expectations and 30% with bearish.

From the overall spotted trades, 4 are puts, for a total amount of $164,211 and 6, calls, for a total amount of $374,017.

Expected Price Movements

Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $120.0 to $165.0 for Johnson & Johnson over the recent three months.

Volume & Open Interest Trends

Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Johnson & Johnson's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Johnson & Johnson's significant trades, within a strike price range of $120.0 to $165.0, over the past month.

Johnson & Johnson Option Volume And Open Interest Over Last 30 Days

Largest Options Trades Observed:

About Johnson & Johnson

Johnson & Johnson is the world's largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women's health. The consumer group is being divested in 2023 under the new name Kenvue. Geographically, just over half of total revenue is generated in the United States.

Having examined the options trading patterns of Johnson & Johnson, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance

Present Market Standing of Johnson & Johnson

• With a volume of 1,812,598, the price of JNJ is down -1.09% at $145.82.
• RSI indicators hint that the underlying stock may be oversold.
• Next earnings are expected to be released in 74 days.

Expert Opinions on Johnson & Johnson

A total of 5 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $187.0.

• An analyst from Morgan Stanley persists with their Equal-Weight rating on Johnson & Johnson, maintaining a target price of $171.
• An analyst from Cantor Fitzgerald downgraded its action to Overweight with a price target of $215.
• Consistent in their evaluation, an analyst from Barclays keeps a Equal-Weight rating on Johnson & Johnson with a target price of $162.
• An analyst from Raymond James persists with their Outperform rating on Johnson & Johnson, maintaining a target price of $172.
• In a cautious move, an analyst from Cantor Fitzgerald downgraded its rating to Overweight, setting a price target of $215.

Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.

If you want to stay updated on the latest options trades for Johnson & Johnson, Benzinga Pro gives you real-time options trades alerts.